Identification and characterization of shared transcriptomic signatures in BRCA2-mutated metastatic breast cancer and lung adenocarcinoma: An integrative bioinformatics approach.
Breast cancer and lung adenocarcinoma (LUAD) are most prevalent forms of malignancies worldwide and are associated with BRCA2 variants. While BRCA2 pathogenic variants are well established in breast cancer, their transcriptional consequences in lung adenocarcinoma remain poorly characterized, and no study has directly...